Lee Gha Young, Kim Nam Hee, Zhao Zheng-Shan, Cha Bong Soo, Kim Yu Sam
Department of Biochemistry, College of Science, Protein Network Research Center, Yonsei University, Seoul, South Korea.
Biochem J. 2004 Mar 15;378(Pt 3):983-90. doi: 10.1042/BJ20031565.
MCD (malonyl-CoA decarboxylase), which catalyses decarboxylation of malonyl-CoA, is known to play an important role in the regulation of malonyl-CoA concentration. Recently, it has been observed that the expression of MCD is significantly decreased in the hearts of the PPARalpha (peroxisome-proliferator-activated receptor alpha) (-/-) mice, where the rate of fatty-acid oxidation is decreased by the increased malonyl-CoA level [Campbell, Kozak, Wagner, Altarejos, Dyck, Belke, Severson, Kelly and Lopaschuk (2002) J. Biol. Chem. 277, 4098-4103]. This suggests that MCD may be transcriptionally regulated by PPARalpha. To investigate whether PPARalpha is truly responsible for transcriptional regulation of the rat MCD gene, transient reporter assay was performed in CV-1 cells. The promoter activity was increased by 17-fold in CV-1 cells co-transfected with PPARalpha/retinoid X receptor alpha expression plasmid. In sequence analysis of the promoter region, three putative PPREs (PPAR response elements) were identified, and promoter deletion analysis showed that PPRE2 and PPRE3 were functional. Electrophoretic mobility-shift assays revealed that PPARalpha/retinoid X receptor alpha heterodimer indeed bound to the two PPREs, and the binding specificity of PPARalpha on PPRE was also confirmed by experiments with mutated oligonucleotides. These results indicate that the elements behaved as a responsive site to PPARalpha activation. MCD mRNA levels in WY14643-treated rat hepatoma cells as well as in the liver of fenofibrate-fed Otsuka Long-Evans Tokushima fatty rats were also found to be increased, suggesting that PPARalpha can activate the rat hepatic MCD transcription by binding to the PPREs in the promoter. We propose that MCD performs an important role in understanding the regulatory mechanism between activated PPARalpha and fatty-acid oxidation by altering the malonyl-CoA concentration.
丙二酰辅酶A脱羧酶(MCD)催化丙二酰辅酶A的脱羧反应,已知其在丙二酰辅酶A浓度调节中发挥重要作用。最近,人们观察到在过氧化物酶体增殖物激活受体α(PPARα)基因敲除(-/-)小鼠的心脏中,MCD的表达显著降低,在这些小鼠中,丙二酰辅酶A水平升高导致脂肪酸氧化速率下降[坎贝尔、科扎克、瓦格纳、阿尔塔雷霍斯、戴克、贝尔克、塞弗森、凯利和洛帕舒克(2002年)《生物化学杂志》277卷,4098 - 4103页]。这表明MCD可能受PPARα的转录调控。为研究PPARα是否真的负责大鼠MCD基因的转录调控,在CV - 1细胞中进行了瞬时报告基因检测。与PPARα/视黄酸X受体α表达质粒共转染的CV - 1细胞中,启动子活性增加了17倍。在启动子区域的序列分析中,鉴定出三个假定的PPAR反应元件(PPRE),启动子缺失分析表明PPRE2和PPRE3具有功能。电泳迁移率变动分析显示PPARα/视黄酸X受体α异二聚体确实与这两个PPRE结合,用突变寡核苷酸进行的实验也证实了PPARα对PPRE的结合特异性。这些结果表明这些元件是对PPARα激活的反应位点。在经WY14643处理的大鼠肝癌细胞以及非诺贝特喂养的大冢长 - 埃文斯德岛肥胖大鼠的肝脏中,也发现MCD mRNA水平升高,这表明PPARα可通过与启动子中的PPRE结合来激活大鼠肝脏中的MCD转录。我们认为,MCD通过改变丙二酰辅酶A浓度,在理解激活的PPARα与脂肪酸氧化之间的调控机制中发挥重要作用。